Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines

COVID-19 vaccines have been developed with unprecedented speed which would not have been possible without decades of fundamental research on delivery nanotechnology. Lipid-based nanoparticles have played a pivotal role in the successes of COVID-19 vaccines and many other nanomedicines, such as Doxil...

Descripción completa

Detalles Bibliográficos
Autores principales: Thi, Thai Thanh Hoang, Suys, Estelle J. A., Lee, Jung Seok, Nguyen, Dai Hai, Park, Ki Dong, Truong, Nghia P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069344/
https://www.ncbi.nlm.nih.gov/pubmed/33918072
http://dx.doi.org/10.3390/vaccines9040359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069344/
https://www.ncbi.nlm.nih.gov/pubmed/33918072
http://dx.doi.org/10.3390/vaccines9040359

Ejemplares similares